Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET

Zhen J. Wang, Gautham P. Reddy, Michael Gotway, Charles B. Higgins, David M. Jablons, Mohan Ramaswamy, Randall A. Hawkins, W. Richard Webb

Research output: Contribution to journalReview article

137 Citations (Scopus)

Abstract

Imaging plays an essential role in the evaluation of malignant pleural mesothelioma (MPM). Computed tomography is the primary imaging modality used for the diagnosis and staging of MPM. Magnetic resonance (MR) imaging and, more recently, positron emission tomography (PET) have emerged as modalities that can provide additional important diagnostic and prognostic information to help further delineate the extent of disease, especially in surgical candidates. Use of MR imaging performed with different pulse sequences and gadolinium-based contrast material can improve the detection of tumor extension, especially to the chest wall and diaphragm. PET can provide both anatomic and metabolic information, especially in cases of extrathoracic and mediastinal nodal metastasis. Each imaging modality has its advantages and limitations, but their combined use is crucial in determining the most appropriate treatment options for patients with MPM.

Original languageEnglish (US)
Pages (from-to)105-119
Number of pages15
JournalRadiographics
Volume24
Issue number1
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

Positron-Emission Tomography
Magnetic Resonance Imaging
Gadolinium
Thoracic Wall
Diaphragm
Contrast Media
Tomography
Neoplasm Metastasis
Malignant Mesothelioma
Neoplasms
Therapeutics

Keywords

  • Mesothelioma, 66.3254
  • Pleura, CT, 66.1211
  • Pleura, MR, 66.1214
  • Pleura, neoplasms, 66.3254
  • Pleura, PET, 66.12163

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Wang, Z. J., Reddy, G. P., Gotway, M., Higgins, C. B., Jablons, D. M., Ramaswamy, M., ... Webb, W. R. (2004). Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET. Radiographics, 24(1), 105-119.

Malignant Pleural Mesothelioma : Evaluation with CT, MR Imaging, and PET. / Wang, Zhen J.; Reddy, Gautham P.; Gotway, Michael; Higgins, Charles B.; Jablons, David M.; Ramaswamy, Mohan; Hawkins, Randall A.; Webb, W. Richard.

In: Radiographics, Vol. 24, No. 1, 01.2004, p. 105-119.

Research output: Contribution to journalReview article

Wang, ZJ, Reddy, GP, Gotway, M, Higgins, CB, Jablons, DM, Ramaswamy, M, Hawkins, RA & Webb, WR 2004, 'Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET', Radiographics, vol. 24, no. 1, pp. 105-119.
Wang ZJ, Reddy GP, Gotway M, Higgins CB, Jablons DM, Ramaswamy M et al. Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET. Radiographics. 2004 Jan;24(1):105-119.
Wang, Zhen J. ; Reddy, Gautham P. ; Gotway, Michael ; Higgins, Charles B. ; Jablons, David M. ; Ramaswamy, Mohan ; Hawkins, Randall A. ; Webb, W. Richard. / Malignant Pleural Mesothelioma : Evaluation with CT, MR Imaging, and PET. In: Radiographics. 2004 ; Vol. 24, No. 1. pp. 105-119.
@article{d111557a3b68466daa5ee3dbfa8fdc21,
title = "Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET",
abstract = "Imaging plays an essential role in the evaluation of malignant pleural mesothelioma (MPM). Computed tomography is the primary imaging modality used for the diagnosis and staging of MPM. Magnetic resonance (MR) imaging and, more recently, positron emission tomography (PET) have emerged as modalities that can provide additional important diagnostic and prognostic information to help further delineate the extent of disease, especially in surgical candidates. Use of MR imaging performed with different pulse sequences and gadolinium-based contrast material can improve the detection of tumor extension, especially to the chest wall and diaphragm. PET can provide both anatomic and metabolic information, especially in cases of extrathoracic and mediastinal nodal metastasis. Each imaging modality has its advantages and limitations, but their combined use is crucial in determining the most appropriate treatment options for patients with MPM.",
keywords = "Mesothelioma, 66.3254, Pleura, CT, 66.1211, Pleura, MR, 66.1214, Pleura, neoplasms, 66.3254, Pleura, PET, 66.12163",
author = "Wang, {Zhen J.} and Reddy, {Gautham P.} and Michael Gotway and Higgins, {Charles B.} and Jablons, {David M.} and Mohan Ramaswamy and Hawkins, {Randall A.} and Webb, {W. Richard}",
year = "2004",
month = "1",
language = "English (US)",
volume = "24",
pages = "105--119",
journal = "Radiographics",
issn = "0271-5333",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Malignant Pleural Mesothelioma

T2 - Evaluation with CT, MR Imaging, and PET

AU - Wang, Zhen J.

AU - Reddy, Gautham P.

AU - Gotway, Michael

AU - Higgins, Charles B.

AU - Jablons, David M.

AU - Ramaswamy, Mohan

AU - Hawkins, Randall A.

AU - Webb, W. Richard

PY - 2004/1

Y1 - 2004/1

N2 - Imaging plays an essential role in the evaluation of malignant pleural mesothelioma (MPM). Computed tomography is the primary imaging modality used for the diagnosis and staging of MPM. Magnetic resonance (MR) imaging and, more recently, positron emission tomography (PET) have emerged as modalities that can provide additional important diagnostic and prognostic information to help further delineate the extent of disease, especially in surgical candidates. Use of MR imaging performed with different pulse sequences and gadolinium-based contrast material can improve the detection of tumor extension, especially to the chest wall and diaphragm. PET can provide both anatomic and metabolic information, especially in cases of extrathoracic and mediastinal nodal metastasis. Each imaging modality has its advantages and limitations, but their combined use is crucial in determining the most appropriate treatment options for patients with MPM.

AB - Imaging plays an essential role in the evaluation of malignant pleural mesothelioma (MPM). Computed tomography is the primary imaging modality used for the diagnosis and staging of MPM. Magnetic resonance (MR) imaging and, more recently, positron emission tomography (PET) have emerged as modalities that can provide additional important diagnostic and prognostic information to help further delineate the extent of disease, especially in surgical candidates. Use of MR imaging performed with different pulse sequences and gadolinium-based contrast material can improve the detection of tumor extension, especially to the chest wall and diaphragm. PET can provide both anatomic and metabolic information, especially in cases of extrathoracic and mediastinal nodal metastasis. Each imaging modality has its advantages and limitations, but their combined use is crucial in determining the most appropriate treatment options for patients with MPM.

KW - Mesothelioma, 66.3254

KW - Pleura, CT, 66.1211

KW - Pleura, MR, 66.1214

KW - Pleura, neoplasms, 66.3254

KW - Pleura, PET, 66.12163

UR - http://www.scopus.com/inward/record.url?scp=1642578801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642578801&partnerID=8YFLogxK

M3 - Review article

C2 - 14730040

AN - SCOPUS:1642578801

VL - 24

SP - 105

EP - 119

JO - Radiographics

JF - Radiographics

SN - 0271-5333

IS - 1

ER -